NEMUS Bioscience picks up $5 mln

Costa Mesa, California-based NEMUS Bioscience Inc, a biopharmaceutical company focused on developing cannabis-based therapies, has raised $5 million in Series B funding. The investors were not named. Midtown Partners & Co was the placement agent.

21 August 2015•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail